Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

Share Price is delayed by 15 minutes
Get Live Data
19.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.50 (8.108%)
Market Cap: £44.16m
GELN Live PriceLast checked at - London Stock Exchange

Intraday Gelion Share Chart

Director/PDMR Shareholding

17 Mar 2023 10:45

RNS Number : 3785T
Gelion PLC
17 March 2023
 

 

Gelion plc

('Gelion' or the 'Company') 

 

Director/PDMR Shareholding

 

The Company was notified on 16 March 2023 that John Wood, Chief Executive Officer, purchased 24,000 Ordinary Shares of 0.1p each ("Ordinary Shares") at a price of 41.8 pence per Ordinary Share.

 

As a result of this transaction, John Wood's beneficial interest in the Company is 48,000 Ordinary Shares representing 0.04 per cent. of the Company's total voting rights.

 

 

 

Enquiries:

 

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

via Alma PR

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Christopher Raggett

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 

Alma PR (Financial PR Adviser)

Justine James

Josh Royston

Hannah Campbell

Will Ellis-Hancock

+44 20 3405 0205

gelion@almapr.co.uk

 

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Wood

2.

Reason for the Notification

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gelion plc

b)

LEI

2138008NC7YL3MCUDR84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BNBQZD59

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

No. of Shares

Price

24,000

£0.418

d)

Aggregated information:

· Aggregated volume

· Price

See above

e)

Date of the transaction

16 March 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDXXXBDGXR
Date   Source Headline
4th Jun 202612:53 pmRNS-RPublication of Research Report
2nd Jun 20267:00 amRNSNissan Project, Grant Award, Investor Presentation
21st May 20267:00 amRNSHolding(s) in Company
13th Apr 20267:00 amRNS-RQ1 2026 Newsletter
31st Mar 20267:00 amRNSExceptional Technical Results
3rd Mar 20268:32 amRNSDirector/PDMR Shareholding - Grant of options
2nd Mar 20267:00 amRNSHalf year results to 31 December 2025
11th Feb 20267:00 amRNSBusiness Update, Notice of Results & IMC
4th Feb 20267:00 amRNSChange of Registered Office
27th Jan 20268:02 amRNSBlock Admission Return
15th Jan 20267:00 amRNSProf. Rachid Yazami Appointed Technology Advisor
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
24th Dec 20259:24 amRNSDirector Dealing
24th Dec 20259:24 amRNSDirector Dealing
22nd Dec 202512:18 pmRNSResult of AGM
22nd Dec 202512:18 pmRNSResult of AGM
11th Dec 20257:00 amRNS-RChange of Name of OXLiD Ltd to Gelion Europe Ltd
10th Dec 20258:59 amRNSDirector/PDMR Shareholding - Grant of Options
4th Dec 20257:00 amRNSGelion Achieves Key Industry Technical Milestone
27th Nov 20257:01 amRNSNotice of AGM
27th Nov 20257:00 amRNSFinal results to 30 June 2025
25th Nov 20258:30 amRNSNotice of Results and Investor Presentation
5th Nov 20259:21 amRNSResult of GM, PDMR Dealings & Total Voting Rights
29th Oct 20257:00 amRNS-RGeneral Meeting Information
21st Oct 20257:00 amRNSResult of Oversubscribed WRAP Retail Offer
21st Oct 20257:00 amRNSFull Collaboration Agreement with TDK
20th Oct 20254:30 pmRNSEarly Close of WRAP Retail Offer
17th Oct 202510:34 amRNSResult of Placing and Subscription
16th Oct 20255:30 pmRNSWRAP Retail Offer for up to £500k
16th Oct 20254:43 pmRNSProposed Placing, Subscription & Retail Offer
16th Oct 20254:35 pmRNSThree Li-S Patents Advance Successfully in U.S.
16th Oct 20254:35 pmRNSSulfur CAM: Drop-In for Existing Battery Plants
16th Oct 20254:35 pmRNSCollaboration with Tier-One Battery Partner
19th Sep 20257:30 amRNSOXLiD funding for Li-S project with QinetiQ
15th Sep 20257:00 amRNSHigh Lithium Recovery at Battery Minerals Ltd
3rd Sep 20257:00 amRNSSuccessful MPI Tech Transfer & Sulfur CAM Scale-Up
5th Aug 20257:00 amRNSGelion Achieves Breakthrough in Li-S Performance
1st Aug 20257:00 amRNSNotification of Major Holdings
28th Jul 20257:00 amRNSBlock Admission Return
14th Jul 20257:00 amRNSGrant Funding & Commissioning of Prototyping Line
8th Jul 20257:00 amRNSCommencement of £2.3m Australian Government Grant
1st Jul 20257:00 amRNSSuccessful Installation of 4-MWh BESS
26th Jun 20257:07 amRNSStrong Progress at Battery Minerals
5th Jun 20259:16 amRNSHolding(s) in Company
5th Jun 20259:15 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDirector Holdings
20th May 20257:00 amRNSDirector Dealing
6th May 20254:07 pmRNSResult of GM, PDMR Dealings & Total Voting Rights
30th Apr 202511:42 amRNSDirector/PDMR Shareholding - Grant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.